6:09 PM
 | 
Feb 06, 2013
 |  BC Extra  |  Company News

GSK restructuring European business

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) CEO Andrew Witty said the pharma will restructure its European pharmaceuticals business because of a "sustained shift we have witnessed in the European reimbursement and pricing...

Read the full 135 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >